Form 483

Qualgen, LLC Form 483, 2017-05-10

FDA issued a Form 483 to Qualgen, LLC on 2017-05-10 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

Qualgen, LLC · Edmond, United States · Issued May 10, 2017

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

10 May 2017
21 CFR 211.110(a)

Written in-process control procedures

Cited by Margaret M Annes

10 May 2017
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by Margaret M Annes

10 May 2017
21 CFR 211.165(b)

Microbiological testing

Cited by Margaret M Annes

10 May 2017
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Margaret M Annes

10 May 2017
21 CFR 211.42(c)

Defined areas of adequate size for operations

Cited by Margaret M Annes

Inspected site

QLQualgen, LLCEdmond, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere